Association of serum Epstein-Barr nuclear antigen-1 antibodies and intrathecal immunoglobulin synthesis in early multiple sclerosis

Journal of Neuroimmunology

Volumn 285, Issue , 2015, Pages 156-160

  Pfuhl, Catherina ^a   Oechtering, Johanna ^a   Rasche, Ludwig ^a   Gieß, René M ^a   Behrens, Janina R ^a   Wakonig, Katharina ^a   Freitag, Erik ^a   Pache, Florence C ^a   Otto, Carolin ^b   Hofmann, Jörg ^a   Eberspächer, Bettina ^a   Bellmann Strobl, Judith ^a   Paul, Friedemann ^a   Ruprecht, Klemens ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b St Josefs Krankenhaus Potsdam Sanssouci   (Germany)

Author keywords

Antibodies; Epstein Barr nuclear antigen 1; Epstein Barr virus; Intrathecal immunoglobulin G; Multiple sclerosis; Oligoclonal bands

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS NUCLEAR ANTIGEN 1 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN; BIOLOGICAL MARKER; CAPSID PROTEIN; EBV-ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN-BARR VIRAL CAPSID ANTIGEN; IMMUNOGLOBULIN G; VIRUS ANTIGEN;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RUBELLA; VARICELLA ZOSTER VIRUS; ADOLESCENT; BIOSYNTHESIS; BLOOD; COHORT ANALYSIS; EARLY DIAGNOSIS; METABOLISM; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROSPECTIVE STUDY; SPINAL CORD; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BIOLOGICAL MARKERS; CAPSID PROTEINS; COHORT STUDIES; EARLY DIAGNOSIS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROSPECTIVE STUDIES; SPINAL CORD; YOUNG ADULT;

EID: 84943226475     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.06.012     Document Type: Article

References (28)

1. Ascherio A. Environmental factors in multiple sclerosis. Expert. Rev. Neurother. 2013, 13:3-9.
2. Ascherio A., Munger K.L. Environmental risk factors for multiple sclerosis. part I: the role of infection. Ann. Neurol. 2007, 61:288-299.
3. Ascherio A., Munger K.L., Lunemann J.D. The initiation and prevention of multiple sclerosis. Nat. Rev. Neurol. 2012, 8:602-612.
4. Buljevac D., van Doornum G.J., Flach H.Z., Groen J., Osterhaus A.D., Hop W., van Doorn P.A., van der Meche F.G., Hintzen R.Q. Epstein-Barr virus and disease activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2005, 76:1377-1381.
5. Comabella M., Kakalacheva K., Rio J., Munz C., Montalban X., Lunemann J.D. EBV-specific immune responses in patients with multiple sclerosis responding to IFNbeta therapy. Mult. Scler. 2012, 18:605-609.
6. Handel A.E., Williamson A.J., Disanto G., Handunnetthi L., Giovannoni G., Ramagopalan S.V. An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One 2010, 5:e12496.
7. Imrell K., Landtblom A.M., Hillert J., Masterman T. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 2006, 67:1062-1064.
8. Jafari N., van Nierop G.P., Verjans G.M., Osterhaus A.D., Middeldorp J.M., Hintzen R.Q. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis. J. Clin. Virol. 2010, 49:26-31.
9. Kuhle J., Disanto G., Dobson R., Adiutori R., Bianchi L., Topping J., Bestwick J., Meier U.C., Marta M., Costa G.D., Runia T., Evdoshenko E., Lazareva N., Thouvenot E., Iaffaldano P., Direnzo V., Khademi M., Piehl F., Comabella M., Sombekke M., Killestein J., Hegen H., Rauch S., D'Alfonso S., Alvarez-Cermeno J., Kleinova P., Horakova D., Roesler R., Lauda F., Llufriu S., Avsar T., Uygunoglu U., Altintas A., Saip S., Menge T., Rajda C., Bergamaschi R., Moll N., Khalil M., Marignier R., Dujmovic I., Larsson H., Malmestrom C., Scarpini E., Fenoglio C., Wergeland S., Laroni A., Annibali V., Romano S., Martinez A., Carra A., Salvetti M., Uccelli A., Torkildsen O., Myhr K., Galimberti D., Rejdak K., Lycke J., Frederiksen J., Drulovic J., Confavreux C., Brassat D., Enzinger C., Fuchs S., Bosca I., Pelletier J., Picard C., Colombo E., Franciotta D., Derfuss T., Lindberg R., Yaldizli O., Vecsei L., Kieseier B., Hartung H., Villoslada P., Siva A., Saiz A., Tumani H., Havrdova E., Villar L., Leone M., Barizzone N., Deisenhammer F., Teunissen C., Montalban X., Tintore M., Olsson T., Trojano M., Lehmann S., Castelnovo G., Lapin S., Hintzen R., Kappos L., Furlan R., Martinelli V., Comi G., Ramagopalan S., Giovannoni G. Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study 2015, Mult Scler.
10. Leone M.A., Barizzone N., Esposito F., Lucenti A., Harbo H.F., Goris A., Kockum I., Oturai A.B., Celius E.G., Mero I.L., Dubois B., Olsson T., Sondergaard H.B., Cusi D., Lupoli S., Andreassen B.K., Myhr K.M., Guerini F.R., Comi G., Martinelli-Boneschi F., D'Alfonso S. Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients. PLoS One 2013, 8:e64408.
11. Levin L.I., Munger K.L., O'Reilly E.J., Falk K.I., Ascherio A. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann. Neurol. 2010, 67:824-830.
12. Lucas R.M., Ponsonby A.L., Dear K., Valery P., Pender M.P., Burrows J.M., Burrows S.R., Chapman C., Coulthard A., Dwyer D.E., Dwyer T., Kilpatrick T., Lay M.L., McMichael A.J., Taylor B.V., van der Mei I.A., Williams D. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology 2011, 77:371-379.
13. McClain M.T., Rapp E.C., Harley J.B., James J.A. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. J. Med. Virol. 2003, 70:253-257.
14. Mero I.L., Gustavsen M.W., Saether H.S., Flam S.T., Berg-Hansen P., Sondergaard H.B., Jensen P.E., Berge T., Bjolgerud A., Muggerud A., Aarseth J.H., Myhr K.M., Celius E.G., Sellebjerg F., Hillert J., Alfredsson L., Olsson T., Oturai A.B., Kockum I., Lie B.A., Andreassen B.K., Harbo H.F. Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. PLoS One 2013, 8:e58352.
15. Montalban X. CIS diagnostics and predictors of conversion to CDMS. Mult. Scler. Relat. Disord. 2014, 3:764.
16. Munger K.L., Levin L.I., O'Reilly E.J., Falk K.I., Ascherio A. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult. Scler. 2011, 17:1185-1193.
17. Otto C., Oltmann A., Stein A., Frenzel K., Schroeter J., Habbel P., Gartner B., Hofmann J., Ruprecht K. Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis. Neurology 2011, 76:1316-1321.
18. Petereit H.F., Reske D. Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients - follow-up and clinical implications. Cerebrospinal Fluid Res. 2005, 2:3.
19. Pohl D., Rostasy K., Jacobi C., Lange P., Nau R., Krone B., Hanefeld F. Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis. J. Neurol. 2009, 257:212-216.
20. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., Fujihara K., Havrdova E., Hutchinson M., Kappos L., Lublin F.D., Montalban X., O'Connor P., Sandberg-Wollheim M., Thompson A.J., Waubant E., Weinshenker B., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
21. Raffel J., Dobson R., Gafson A., Mattoscio M., Muraro P., Giovannoni G. Multiple sclerosis therapy and Epstein-Barr virus antibody titres. Mult. Scler. Relat. Disord. 2014, 3:372-374.
22. Reiber H. Cerebrospinal fluid - physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases. Mult. Scler. 1998, 4:99-107.
23. Reiber H., Teut M., Pohl D., Rostasy K.M., Hanefeld F. Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid. Mult. Scler. 2009, 15:1466-1480.
24. Rickinson A.B., KieffE. Epstein-Barr virus. Virology 2001, 2575-2627. Lippincott Williams and Wilkins, New York. D.M. Knipe, P.M. Howley (Eds.).
25. Rudick R.A., Cookfair D.L., Simonian N.A., RansohoffR.M., Richert J.R., Jacobs L.D., Herndon R.M., Salazar A.M., Fischer J.S., Granger C.V., Goodkin D.E., Simon J.H., Bartoszak D.M., Bourdette D.N., Braiman J., Brownscheidle C.M., Coats M.E., Cohan S.L., Dougherty D.S., Kinkel R.P., Mass M.K., Munchsauer F.E., O'Reilly K., Priore R.L., Whitham R.H., et al. Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. J. Neuroimmunol. 1999, 93:8-14.
26. Sundqvist E., Sundstrom P., Linden M., Hedstrom A.K., Aloisi F., Hillert J., Kockum I., Alfredsson L., Olsson T. Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun. 2012, 13:14-20.
27. Walsh M.J., Tourtellotte W.W. Temporal invariance and clonal uniformity of brain and cerebrospinal IgG, IgA, and IgM in multiple sclerosis. J. Exp. Med. 1986, 163:41-53.
28. Waubant E., Mowry E.M., Krupp L., Chitnis T., Yeh E.A., Kuntz N., Ness J., Belman A., Milazzo M., Gorman M., Weinstock-Guttman B., Rodriguez M., James J.A. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis. Mult. Scler. 2013, 19:891-895.